Kinard S. David's most recent trade in Elanco Animal Health Inc was a trade of 46,383 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 46,383 | 46,383 | - | - | Employee Stock Option (right to buy) | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 22,105 | 188,878 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.17 per share. | 01 Mar 2025 | 7,162 | 166,773 (0%) | 0% | 11.2 | 80,000 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 40,247 | 191,903 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.24 per share. | 19 Feb 2025 | 17,968 | 173,935 (0%) | 0% | 11.2 | 201,960 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,014 | 34,014 | - | - | Employee Stock Option(right to buy) | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 15,596 | 155,377 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.03 per share. | 01 Mar 2024 | 5,731 | 149,646 (0%) | 0% | 16.0 | 91,868 | Common Stock |
| Elanco Animal Health Inc | Kinard S. David | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 14,562 | 146,406 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Kinard S. David | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share. | 27 Feb 2024 | 6,625 | 139,781 (0%) | 0% | 16.5 | 109,048 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 28,571 | 142,112 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 02 Mar 2023 | 12,419 | 129,693 (0%) | 0% | 11.0 | 136,733 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 50,863 | 50,863 | - | - | Employee Stock Option (right to buy) | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 22,270 | 115,130 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 01 Mar 2023 | 2,482 | 92,860 (0%) | 0% | 11.3 | 27,947 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 01 Mar 2023 | 1,009 | 113,541 (0%) | 0% | 11.0 | 11,109 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 23,026 | 23,026 | - | - | Employee Stock Option(right to buy) | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,665 | 97,241 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.94 per share. | 01 Mar 2022 | 1,724 | 95,517 (0%) | 0% | 28.9 | 49,893 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.00 per share. | 01 Mar 2022 | 874 | 94,643 (0%) | 0% | 29 | 25,346 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 22,598 | 97,976 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 22 Feb 2022 | 9,400 | 88,576 (0%) | 0% | 26.0 | 244,212 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.66 per share. | 20 Oct 2021 | 2,065 | 75,378 (0%) | 0% | 33.7 | 69,508 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 6,717 | 78,499 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.34 per share. | 01 Mar 2021 | 573 | 77,443 (0%) | 0% | 32.3 | 18,531 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.65 per share. | 01 Mar 2021 | 483 | 78,016 (0%) | 0% | 33.7 | 16,253 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 13,540 | 75,652 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.58 per share. | 22 Feb 2021 | 3,870 | 71,782 (0%) | 0% | 30.6 | 118,345 | Common Stock |
| Elanco Animal Health Inc | David S. Kinard | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.67 per share. | 31 Dec 2020 | 5,354 | 62,112 (0%) | 0% | 30.7 | 164,207 | Common Stock |